CARDIOVASCULAR
hamburger

Heart failure is a widespread condition affecting 6.2 million adults in the United States.1

Receiving a heart failure diagnosis can be difficult, but you’re not alone. More people than ever are living longer and improving their quality of life with today’s heart failure management options.

If you have NYHA Class III heart failure and have been hospitalized in the past year, it may be time to talk to your doctor about pulmonary artery (PA) pressure monitoring.

The CardioMEMS™ HF System is the only FDA-approved PA pressure monitor that can improve your quality of life, and could reduce your risk for hospitalization.2

How Can the CardioMEMS HF System Help You Stay Ahead of Heart Failure?

Pulmonary artery (PA) pressure monitoring provides early detection of worsening heart failure, long before symptoms such as weight gain or blood pressure. Daily pressure readings from home can proactively inform your care team of any needed adjustments to your medications and/or lifestyle without a hospital or clinic visit.

How Does Remote PA Pressure Monitoring Work?

Icons showing PA pressure monitoring steps. First, the sensor is inserted via right heart catherization. Second, patients take daily sensor readings from the comfort of their home. Third, data wirelessly transmitted to clinician’s secure website. And finally, clinician reviews data and contacts patient as necessary.
Find a Doc

Find a clinic and learn more.

Find a heart failure clinic near you that offers the CardioMEMS HF System or call 1-855-4-CMEMSHF

  • Frequently asked questions about the CardioMEMS HF System

  • Your First Visit to a Heart Failure Clinic: What to Expect

Become Ambassador

Talk to someone who is benefitting from a CardioMEMS HF System

Patient Ambassadors are volunteers who are ready to share their real-life experiences with heart failure and the CardioMEMS HF System. They can answer questions about heart failure and the solutions they chose to manage their heart failure.

Already have the CardioMEMS HF System?

Find information about setting up and using your device or call 1-844-myCMEMS

References

  1. Virano SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020;141:e139-e596.
  2. Abraham, W. T., Stevenson, L. W., Bourge, R. C., Lindenfeld, J. A., Bauman, J. G., Adamson, P. B., for the CHAMPION Trial Study Group. (2016). Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. The Lancet, 387(10017), 453-461.

Indications, Safety and Warnings

Rx Only

Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

Indications and Usage: The CardioMEMS™ HF System is indicated for wirelessly measuring and monitoring pulmonary artery (PA) pressure and heart rate in New York Heart Association (NYHA) Class III heart failure patients who have been hospitalized for heart failure in the previous year. The hemodynamic data are used by physicians for heart failure management and with the goal of reducing heart failure hospitalizations.

Contraindications: The CardioMEMS™ HF System is contraindicated for patients with an inability to take dual antiplatelet or anticoagulants for one month post implant.

Potential Adverse Events: Potential adverse events associated with the implantation procedure include, but are not limited to the following: Infection, Arrhythmias, Bleeding, Hematoma, Thrombus, Myocardial infarction, Transient ischemic attack, Stroke, Death, and Device embolization.

Refer to the Instructions for Use for detailed indications, contraindications, warnings, precautions and potential adverse events.

INDICATIONS, SAFETY & WARNINGS

MAT-2002896 v6.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.